Published Mar 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

Member News

Related or similar articles

June 18, 2024

Labshares Announces Key Leadership Additions: Devon Lagasse Joins as VP of Growth and Emma Orfanos Is Promoted to Manager of Business Development

Labshares appoints a Devon Lagasse as VP of Growth and promotes Emma Orfanos to Manager of Business Development, strengthening its leadership as the Greater Boston shared lab provider expands.
Press Releases
September 3, 2026

K2B Therapeutics: Journey from Incubator to Labshares

Learn how K2B Therapeutics transitioned from the traditional incubator model to Labshares. The team was fully operational in less than 2 weeks, and now has the flexibility and support to continue growing.
Blog Posts
May 12, 2025

Leasing / Subleasing vs. Shared Labs: Why Labshares is the Capital-Efficient Choice for Biotechs

Shared labs offer emerging biotechs a flexible, capital-efficient alternative to leasing or subleasing. Labshares combines lab space, advanced equipment, and operational support with 60-70% cost savings.
Blog Posts